Latest Press Releases Innate Pharma to present adenosine franchise, IPH5201 and IPH5301 at ESMO IO 2022 December 1, 2022 Innate Pharma Reports Third Quarter Financial Results November 14, 2022 Innate Pharma announces conference call and webcast for third quarter 2022 business update November 7, 2022 Selected media ANKET: Our NK cell engager platform Thu, 06/10/2021 - 07:00 Click here to learn more about ANKETTM Read more about ANKET: Our NK cell engager platform Interview of Eric Vivier “The new generation of NK cell therapies” Fri, 02/05/2021 - 08:00 Interview Eric Vivier "The new generation of NK cell therapies" Read more about Interview of Eric Vivier “The new generation of NK cell therapies” How NK cells work Fri, 01/01/2021 - 12:00 Read more about How NK cells work
Innate Pharma announces conference call and webcast for third quarter 2022 business update November 7, 2022
ANKET: Our NK cell engager platform Thu, 06/10/2021 - 07:00 Click here to learn more about ANKETTM Read more about ANKET: Our NK cell engager platform
Interview of Eric Vivier “The new generation of NK cell therapies” Fri, 02/05/2021 - 08:00 Interview Eric Vivier "The new generation of NK cell therapies" Read more about Interview of Eric Vivier “The new generation of NK cell therapies”
